StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30
$0.80−0.01 (-0.86%)

Close on Nov 16, 2026Market cap $103.34MP/E –Yield –

Organogenesis operating margin

Operating margin is operating income as a percentage of revenue.

Organogenesis's operating margin for the twelve months ending Jun 30, 2026 was -7.8%. For fiscal 2025 it was 7.9%, against -0.3% the year before. The highest annual figure on record is 15.5% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20257.9%+8.2
FY2024Dec 31, 2024-0.3%−3.2
FY2023Dec 31, 20232.9%−2.1
FY2022Dec 31, 20224.9%−10.5
FY2021Dec 31, 202115.5%+7.6
FY2020Dec 31, 20207.9%+19.3
FY2019Dec 31, 2019-11.4%+15.2
FY2018Dec 31, 2018-26.7%−23.9
FY2017Dec 31, 2017-2.8%+3.6
FY2016Dec 31, 2016-6.3%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-116.5%−104.1
Q1 FY2026Mar 31, 2026-185.1%−154.2
Q4 FY2025Dec 31, 202528.1%+20.0
Q3 FY2025Sep 30, 202513.7%+8.3
Q2 FY2025Jun 30, 2025-12.5%−1.8
Q1 FY2025Mar 31, 2025-30.9%−27.3
Q4 FY2024Dec 31, 20248.1%+9.3
Q3 FY2024Sep 30, 20245.4%−2.0
Q2 FY2024Jun 30, 2024-10.7%−19.0
Q1 FY2024Mar 31, 2024-3.5%+0.2
Q4 FY2023Dec 31, 2023-1.3%−8.8
Q3 FY2023Sep 30, 20237.4%+5.9
Q2 FY2023Jun 30, 20238.3%−1.5
Q1 FY2023Mar 31, 2023-3.7%−3.6
Q4 FY2022Dec 31, 20227.5%−7.9
Q3 FY2022Sep 30, 20221.5%−12.8
Q2 FY2022Jun 30, 20229.8%−9.3
Q1 FY2022Mar 31, 2022-0.1%−12.4
Q4 FY2021Dec 31, 202115.4%−4.8
Q3 FY2021Sep 30, 202114.3%−8.3
Q2 FY2021Jun 30, 202119.1%+22.4
Q1 FY2021Mar 31, 202112.3%+36.7
Q4 FY2020Dec 31, 202020.2%+23.1
Q3 FY2020Sep 30, 202022.6%+35.5
Q2 FY2020Jun 30, 2020-3.3%+8.0
Q1 FY2020Mar 31, 2020-24.4%−3.2
Q4 FY2019Dec 31, 2019-2.9%+4.2
Q3 FY2019Sep 30, 2019-12.9%+7.0
Q2 FY2019Jun 30, 2019-11.3%+27.8
Q1 FY2019Mar 31, 2019-21.2%+35.0
Q4 FY2018Dec 31, 2018-7.0%−2.5
Q3 FY2018Sep 30, 2018-19.8%−14.8
Q2 FY2018Jun 30, 2018-39.1%−43.7
Q1 FY2018Mar 31, 2018-56.2%−48.8
Q4 FY2017Dec 31, 2017-4.5%−3.6
Q3 FY2017Sep 30, 2017-5.1%–
Q2 FY2017Jun 30, 20174.6%–
Q1 FY2017Mar 31, 2017-7.5%–
Q4 FY2016Dec 31, 2016-0.9%–

More Organogenesis figures

See a number that looks wrong?